In a report released yesterday, David Windley from Jefferies reiterated a Buy rating on Syneos Health Inc (NASDAQ: SYNH), with a price target of $58. The company’s shares closed yesterday at $50.20.
According to TipRanks.com, Windley is a top 25 analyst with an average return of 22.8% and a 80.8% success rate. Windley covers the Services sector, focusing on stocks such as WellCare Health Plans, PRA Health Sciences, and Charles River Labs.
Syneos Health Inc has an analyst consensus of Strong Buy, with a price target consensus of $54.75.
See today’s analyst top recommended stocks >>
The company has a one-year high of $59.80 and a one-year low of $31.10. Currently, Syneos Health Inc has an average volume of 734.8K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Syneos Health, Inc. engages in the provision of product development and commercial solutions. It operates though the Clinical Solutions and Commercial Solutions segments.
